Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:18:13 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:LGND - LIGAND PHARMACEUTICAL INC - https://www.ligand.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
LGND - Q6.5239.10·239.702.0239.95+2.200.922.15,317330241.98  244.84  239.235247.38  103.432209:57:10May 2715 min RT 2¢

Recent Trades - Last 10 of 330
Time ETExPriceChangeVolume
09:57:10Q239.99042.24044
09:57:10Q240.022.271
09:56:59Q238.670.921
09:56:26Q238.1360.38650
09:56:20Q239.621.8716
09:56:20Q239.671.9250
09:56:20Q239.681.9317
09:56:16Q239.201.4549
09:56:16Q239.201.451
09:56:14Q239.3851.6357

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-27 16:01U:LGNDNews ReleaseLigand to Participate in June Investor Conferences
2026-05-12 16:18U:LGNDNews ReleaseOrchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
2026-05-07 07:00U:LGNDNews ReleaseLigand Reports First Quarter 2026 Financial Results
2026-05-06 08:01U:LGNDNews ReleaseOrchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
2026-05-05 16:01U:LGNDNews ReleaseLigand to Participate in May Investor Conferences
2026-04-27 07:00U:LGNDNews ReleaseLigand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator
2026-04-22 07:00U:LGNDNews ReleaseLigand to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-14 07:00U:LGNDNews ReleaseLigand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI(TM) (sparsentan) in FSGS
2026-03-26 07:00U:LGNDNews ReleaseLigand Advances Strategic Growth with Expanded and Strengthened Business Development Team
2026-03-04 07:00U:LGNDNews ReleaseLigand to Participate in March Investor Conferences
2026-02-26 07:00U:LGNDNews ReleaseLigand Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-12 07:00U:LGNDNews ReleaseLigand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
2026-02-04 07:00U:LGNDNews ReleaseLigand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
2025-12-09 07:00U:LGNDNews ReleaseLigand Hosts 2025 Investor Day and Introduces 2026 Guidance
2025-11-10 16:11U:LGNDNews ReleaseOrchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
2025-11-06 07:00U:LGNDNews ReleaseLigand Reports Third Quarter 2025 Financial Results and Raises Guidance
2025-10-30 16:01U:LGNDNews ReleaseLigand to Participate in November Investor Conferences
2025-10-23 07:00U:LGNDNews ReleaseLigand to Report Third Quarter 2025 Financial Results on November 6, 2025
2025-10-16 07:00U:LGNDNews ReleaseLigand to Host Investor Day on December 9, 2025